CSPC Pharmaceutical Group Limited (HKG:1093)
9.15
-0.22 (-2.35%)
At close: Mar 9, 2026
CSPC Pharmaceutical Group Employees
CSPC Pharmaceutical Group had 19,266 employees as of June 30, 2025. The number of employees decreased by 2,134 or -9.97% since the number was reported on December 31, 2024.
Employees
19,266
Change
-2,134
Growth
-9.97%
Revenue / Employee
1.49M HKD
Profits / Employee
230.39K HKD
Market Cap
104.61B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 19,266 | -2,134 | -9.97% |
| Dec 31, 2024 | 21,400 | -2,100 | -8.94% |
| Dec 31, 2023 | 23,500 | -1,337 | -5.38% |
| Dec 31, 2022 | 24,837 | 91 | 0.37% |
| Dec 31, 2021 | 24,746 | 3,219 | 14.95% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BeOne Medicines AG | 11,000 |
| Hansoh Pharmaceutical Group Company | 9,313 |
| JD Health International | 5,263 |
| WuXi Biologics | 12,552 |
| Innovent Biologics | 6,190 |
| Sino Biopharmaceutical | 23,056 |
| Akeso | 3,529 |
| Sichuan Kelun-Biotech Biopharmaceutical | 1,870 |
CSPC Pharmaceutical Group News
- 25 days ago - Big Deal, Bigger Doubts: CSPC Slides After $18.5B Pact With AstraZeneca - Benzinga
- 27 days ago - Hong Kong stocks extend bounce-back from tech turbulence as risk sentiment returns - South China Morning Post
- 5 weeks ago - AstraZeneca Strikes Multibillion-Dollar Obesity Deal With China's CSPC - WSJ
- 5 weeks ago - China's CSPC Pharmaceutical inks deal with AstraZeneca for weight loss therapy - Reuters
- 9 months ago - Medtide Launches Hong Kong IPO to Boost Weight-loss Business - Benzinga
- 9 months ago - AstraZeneca Inks China AI Research Deal For Chronic Diseases - NDTV
- 9 months ago - AstraZeneca Inks Research Pact With China's CSPC Pharmaceuticals Focused On AI-Driven Research, Valued Up To $5.33 Billion - Benzinga
- 9 months ago - AstraZeneca signs US$5 billion research deal with China’s CSPC - BNN Bloomberg